Results from the randomized phase 3 POLO trial are in, and the quality of life data shows promise for patients with metastatic pancreatic cancer who harbor a germline BRCA gene mutation.
Eileen M. O'Reily, MD
Advertisement
Articles by Eileen M. O'Reily, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
FDA Approves Oral Nilotinib Tablets for Ph+ CML
3
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
4
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
5